MedTrace Logo

Impact of MELD Score for 1000 Consecutive Liver Transplantations

NCT02548130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2021-08-20

No results posted yet for this study

Summary

The goal of this observational study was to evaluate the impact of the adoption of the MELD system to prioritize patients on the waiting list for OLT on survival for 1000 consecutive liver transplantations. Survival was evaluated on the waiting list, one month, and one year after the transplantation. Another goal was to look at blood losses and transfusion requirement after the adoption of the MELD score. The hypothesis was the MELD system will ameliorate the survival rate on the waiting, but the post-OLT will be worse. Blood losses and transfusions could be worse with the MELD system.

Conditions

  • End Stage Liver Disease

Interventions

OTHER

MELD score

introduction of MELD score

Sponsors & Collaborators

  • Centre hospitalier de l'Université de Montréal (CHUM)

    lead OTHER

Principal Investigators

  • Manon Choiniere, PhD · CrCHUM

Eligibility

Min Age
17 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-29
Primary Completion
2019-07-21
Completion
2019-07-21

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02548130 on ClinicalTrials.gov